Radiopharmaceuticals Market

Radiopharmaceuticals Market Size, Share, Growth Analysis, By Type(Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals), By Application(Diagnostic Applications, SPECT Applications), By Procedural Volume Assessment(Diagnostic Procedures, Therapeutic Procedures), By Source(Nuclear Reactors, Cyclotrons), By End User(Hospitals, Ambulatory Surgical Centers), By Regional(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35I2134 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Radiopharmaceuticals Market Insights

Market Overview:

The worldwide radiopharmaceuticals market is also divided into two categories based on end-user application: hospitals and diagnostic centres. Because of the significant availability of competent medical practitioners in hospital radiology departments, hospitals represented the highest share of this market's revenue in 2012. However, the growing number of diagnostic centres, particularly in developed nations such as the United States, is likely to accelerate the future growth of the radioactive substances for diagnostic centres market.

Radiopharmaceuticals Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for Radiopharmaceuticals was estimated to be valued at US$ XX Mn in 2021.

The global Radiopharmaceuticals Market is estimated to grow at a CAGR of XX% by 2028.

The global Radiopharmaceuticals Market is segmented on the basis of Type, Application, Procedural Volume Assessment, Source, End User, Regional.

Based on region, the global Radiopharmaceuticals Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global Radiopharmaceuticals Market are Cardinal Health Inc., GE Healthcare, IBA Group, Lantheus Medical Imaging, Covidien Plc, Positron Corporation, NTP Radioisotopes Pty Ltd.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Radiopharmaceuticals Market

Product ID: UCMIG35I2134

$5,300
BUY NOW GET FREE SAMPLE